arrow
A

Antonio Dono

mcgovern medical school at uthealth houston
H指数:17
被引数:1,471

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role for surgery in IDH-mutant grade 4 astrocytomas: Interactive effects of resection, patient characteristics, and outcome—Report of the RANO resect group

IDH突变型4级星形细胞瘤中手术的作用:切除、患者特征和预后的交互影响——RANO切除组的报告

2026-08-310
PRE
Safety and effectiveness of stereotactic radiosurgery for larger hemangioblastomas (>2cc): A multi-center retrospective study

立体定向放射外科治疗较大血血管母细胞瘤(>2cc)的安全性和有效性:一项多中心回顾性研究

2026-04-170
OA
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

IDH突变型2级胶质瘤切除范围的预后分类系统:一项由RANO resect group进行外部验证的国际、多中心、回顾性队列研究

2025-11-240
OAAI
Microbial signals in primary and metastatic brain tumors

原发性和转移性脑肿瘤中的微生物信号

2025-11-140
OAAI
The favorable associations between age and supramaximal resection with outcome in glioblastoma - a report of the RANO resect group

年龄与超最大切除对胶质母细胞瘤预后的有利关联——RANO切除组的报告

2025-11-010
OAAI
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group

超切除与胶质母细胞瘤在不同年龄组中的预后关联:RANO切除组的报告

2025-10-250
PRE
DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANORESECT GROUP
2024-11-110
PRE
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: a report of the RANO resect group

新诊断的胶质母细胞瘤术后结果的临床风险模型的开发和验证: RANO切除组的报告

2024-11-040
OAAI
DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP
2024-10-170
PRE
Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis

手术切除对老年胶质母细胞瘤患者预后价值的meta分析

2024-07-111
PRE
Pleomorphic Xanthoastrocytoma: Multi-Institutional Evaluation of Stereotactic Radiosurgery
2024-06-280
PRE